Wansu Park

Wansu Park is a seasoned professional in the pharmaceutical and biotechnology fields, currently serving as a Principal Scientist at Alnylam Pharmaceuticals since March 2022, having previously held the role of Senior Scientist. Prior experience includes positions as a Scientist at Pumas-AI, Inc. and as a Postdoctoral Fellow at the University of Maryland Baltimore in the Center for Translational Medicine. Wansu Park also contributed to research at the FDA as an ORISE Fellow, worked as a Senior Research Scientist at Q-fitter, and was a Research Scientist in DMPK at LG Life Sciences. Educational qualifications include a Ph.D. in Clinical Pharmacology & Pharmacometrics from The Catholic University of Korea, an MS in Pharmaceutical Sciences, and a BS in Pharmacy, both from Kyung Hee University.